GlassScriptPhysician profile
Kathleen Flaherty
NPI 1437690641
$2,928.59
in general payments reported to CMS, 2019-2025
18 companies · $16.30 in 2025
The $16.30 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $721 · 2022: $1,437 · 2023: $502 · 2024: $252 · 2025: $16.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $770.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $769.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,169.22 | 2021-2024 | |
| Neurocrine Biosciences, INC. | $232.00 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $209.93 | 2022 | |
| Alkermes, INC. | $196.23 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $167.87 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $166.83 | 2021-2025 | Rexulti, Abilify Maintena |
| Takeda Pharmaceuticals U.S.A., INC. | $123.48 | 2022 | |
| Bausch Health US, LLC | $112.85 | 2022 | |
| Axsome Therapeutics, INC. | $112.50 | 2023 | Auvelity |
| Vanda Pharmaceuticals INC. | $82.88 | 2022 | |
| Merck Sharp & Dohme LLC | $81.91 | 2022-2023 | Belsomra |
| Lundbeck LLC | $71.75 | 2022 | |
| Idorsia Pharmaceuticals US INC | $57.93 | 2022-2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $38.65 | 2022 | |
| Tris Pharma INC | $37.37 | 2022-2023 | Dyanavel Xr |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $35.00 | 2022 | |
| Corium, LLC | $17.33 | 2022 | |
| Almatica Pharma LLC | $14.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Flaherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.